![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 1514 |
FusionGeneSummary for ALDOA_SCN2A |
![]() |
Fusion gene information | Fusion gene name: ALDOA_SCN2A | Fusion gene ID: 1514 | Hgene | Tgene | Gene symbol | ALDOA | SCN2A | Gene ID | 226 | 6326 |
Gene name | aldolase, fructose-bisphosphate A | sodium voltage-gated channel alpha subunit 2 | |
Synonyms | ALDA|GSD12|HEL-S-87p | BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2 | |
Cytomap | 16p11.2 | 2q24.3 | |
Type of gene | protein-coding | protein-coding | |
Description | fructose-bisphosphate aldolase Aaldolase A, fructose-bisphosphateepididymis secretory sperm binding protein Li 87pfructose-1,6-bisphosphate triosephosphate-lyaselung cancer antigen NY-LU-1muscle-type aldolase | sodium channel protein type 2 subunit alphaHBSC IIsodium channel protein brain II subunit alphasodium channel protein type II subunit alphasodium channel protein, brain type 2 alpha subunitsodium channel, voltage-gated, type II, alpha 1 polypeptides | |
Modification date | 20180522 | 20180527 | |
UniProtAcc | P04075 | Q99250 | |
Ensembl transtripts involved in fusion gene | ENST00000338110, ENST00000395248, ENST00000575627, ENST00000566897, ENST00000569545, ENST00000563060, ENST00000412304, ENST00000564546, ENST00000564595, ENST00000569798, ENST00000395240, | ENST00000375437, ENST00000357398, ENST00000283256, ENST00000375427, | |
Fusion gene scores | * DoF score | 17 X 7 X 10=1190 | 2 X 1 X 1=2 |
# samples | 20 | 2 | |
** MAII score | log2(20/1190*10)=-2.57288966842058 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(2/2*10)=3.32192809488736 | |
Context | PubMed: ALDOA [Title/Abstract] AND SCN2A [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ALDOA | GO:0008360 | regulation of cell shape | 9244396 |
Hgene | ALDOA | GO:0030388 | fructose 1,6-bisphosphate metabolic process | 9244396|14766013 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | LGG | TCGA-CS-6669-01A | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-intron | ENST00000338110 | ENST00000375437 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
5CDS-intron | ENST00000338110 | ENST00000357398 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
5CDS-intron | ENST00000338110 | ENST00000283256 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
5CDS-intron | ENST00000338110 | ENST00000375427 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
3UTR-intron | ENST00000395248 | ENST00000375437 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
3UTR-intron | ENST00000395248 | ENST00000357398 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
3UTR-intron | ENST00000395248 | ENST00000283256 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
3UTR-intron | ENST00000395248 | ENST00000375427 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
intron-intron | ENST00000575627 | ENST00000375437 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
intron-intron | ENST00000575627 | ENST00000357398 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
intron-intron | ENST00000575627 | ENST00000283256 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
intron-intron | ENST00000575627 | ENST00000375427 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
5CDS-intron | ENST00000566897 | ENST00000375437 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
5CDS-intron | ENST00000566897 | ENST00000357398 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
5CDS-intron | ENST00000566897 | ENST00000283256 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
5CDS-intron | ENST00000566897 | ENST00000375427 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
intron-intron | ENST00000569545 | ENST00000375437 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
intron-intron | ENST00000569545 | ENST00000357398 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
intron-intron | ENST00000569545 | ENST00000283256 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
intron-intron | ENST00000569545 | ENST00000375427 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
5CDS-intron | ENST00000563060 | ENST00000375437 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
5CDS-intron | ENST00000563060 | ENST00000357398 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
5CDS-intron | ENST00000563060 | ENST00000283256 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
5CDS-intron | ENST00000563060 | ENST00000375427 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
5CDS-intron | ENST00000412304 | ENST00000375437 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
5CDS-intron | ENST00000412304 | ENST00000357398 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
5CDS-intron | ENST00000412304 | ENST00000283256 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
5CDS-intron | ENST00000412304 | ENST00000375427 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
3UTR-intron | ENST00000564546 | ENST00000375437 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
3UTR-intron | ENST00000564546 | ENST00000357398 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
3UTR-intron | ENST00000564546 | ENST00000283256 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
3UTR-intron | ENST00000564546 | ENST00000375427 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
5CDS-intron | ENST00000564595 | ENST00000375437 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
5CDS-intron | ENST00000564595 | ENST00000357398 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
5CDS-intron | ENST00000564595 | ENST00000283256 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
5CDS-intron | ENST00000564595 | ENST00000375427 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
intron-intron | ENST00000569798 | ENST00000375437 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
intron-intron | ENST00000569798 | ENST00000357398 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
intron-intron | ENST00000569798 | ENST00000283256 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
intron-intron | ENST00000569798 | ENST00000375427 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
intron-intron | ENST00000395240 | ENST00000375437 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
intron-intron | ENST00000395240 | ENST00000357398 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
intron-intron | ENST00000395240 | ENST00000283256 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
intron-intron | ENST00000395240 | ENST00000375427 | ALDOA | chr16 | 30081734 | + | SCN2A | chr2 | 166150541 | + |
Top |
FusionProtFeatures for ALDOA_SCN2A |
![]() |
Hgene | Tgene |
ALDOA | SCN2A |
Plays a key role in glycolysis and gluconeogenesis. Inaddition, may also function as scaffolding protein (Bysimilarity). {ECO:0000250}. | Mediates the voltage-dependent sodium ion permeabilityof excitable membranes. Assuming opened or closed conformations inresponse to the voltage difference across the membrane, theprotein forms a sodium-selective channel through which Na(+) ionsmay pass in accordance with their electrochemical gradient.{ECO:0000269|PubMed:1325650, ECO:0000269|PubMed:17021166,ECO:0000269|PubMed:28256214}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for ALDOA_SCN2A |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for ALDOA_SCN2A |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
ALDOA | XRN1, FANCA, ATP6V1E1, PLD2, USP15, OSBPL10, EGFR, TRIM63, PSMD4, H2AFX, CACNA1A, HDAC5, PCNA, PSMA3, MYC, ISG15, TERF1, CUL3, CUL4B, CUL2, CDK2, MYOC, AKT1, PGK1, ALDOC, HSPD1, LGALS1, LIG4, HSP90AA1, HSP90AB1, VCAM1, FN1, ATF2, IQCB1, MLH1, VCPKMT, ITGA4, RAD52, ALDOB, ALDOA, BCAT2, GALNT6, PIAS4, CS, TNPO3, ADRB2, HUWE1, FUS, IFNA4, SUZ12, HNRNPA1, ACAA2, ACTN4, ACO2, ADI1, ARHGDIA, ASS1, CFL1, COX4I1, ECHS1, FKBP2, GPD1L, GPX4, HSD17B10, IMPA2, ISYNA1, LMAN1, MAP2K7, MYH7B, PKM, SUMO2, TAGLN, TAGLN2, TKT, TRAP1, ATP5J, CKB, CKMT1B, CKMT1A, CKMT2, DUT, ENO1, FABP5, FH, FKBP7, GAPDH, GLO1, HSPE1, KCNAB2, LDHA, LTA4H, NDUFS4, PGAM2, PREP, SOD2, SUMO4, TALDO1, UMPS, NTRK1, HSPB2, SRPK2, AHSA1, CDK2AP1, NCSTN, NCAPH, VPS18, DRC1, MCM2, CDC73, CDH1, CARM1, DNM1L, SOAT1, SOD1, TRIM25, BRCA1 | SCN2A |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for ALDOA_SCN2A |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | ALDOA | P04075 | DB01593 | Zinc | Fructose-bisphosphate aldolase A | small molecule | approved|investigational |
Hgene | ALDOA | P04075 | DB11638 | Artenimol | Fructose-bisphosphate aldolase A | small molecule | approved|investigational |
Tgene | SCN2A | Q99250 | DB00555 | Lamotrigine | Sodium channel protein type 2 subunit alpha | small molecule | approved|investigational |
Tgene | SCN2A | Q99250 | DB00909 | Zonisamide | Sodium channel protein type 2 subunit alpha | small molecule | approved|investigational |
Tgene | SCN2A | Q99250 | DB00818 | Propofol | Sodium channel protein type 2 subunit alpha | small molecule | approved|investigational|vet_approved |
Top |
RelatedDiseases for ALDOA_SCN2A |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | ALDOA | C0272066 | Glycogen Storage Disease XII | 3 | CTD_human;ORPHANET;UNIPROT |
Hgene | ALDOA | C0027626 | Neoplasm Invasiveness | 1 | CTD_human |
Hgene | ALDOA | C0027627 | Neoplasm Metastasis | 1 | CTD_human |
Hgene | ALDOA | C0151744 | Myocardial Ischemia | 1 | CTD_human |
Hgene | ALDOA | C0152013 | Adenocarcinoma of lung (disorder) | 1 | CTD_human |
Hgene | ALDOA | C1458155 | Mammary Neoplasms | 1 | CTD_human |
Tgene | SCN2A | C1843140 | SEIZURES, BENIGN FAMILIAL INFANTILE, 3 | 5 | UNIPROT |
Tgene | SCN2A | C3150987 | EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11 | 5 | CTD_human;UNIPROT |
Tgene | SCN2A | C0014544 | Epilepsy | 2 | CTD_human;HPO |
Tgene | SCN2A | C0009952 | Febrile Convulsions | 1 | CTD_human;HPO |